3 A–C), the antagonist treatment showed a trend toward decreased withdrawal thresholds (ie, increased mechanosensitivity) at the dose of 0.1 μg.
← all excerpts
Modulation of mechanosensation by endogenous dopaminergic signaling in the lateral parabrachial nucleus in mice.
1
—
—